ARCHIVES

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: William McGuire, Breast Cancer Researcher, Dead of Heart Attack; Attracted Large Group To Texas

April 10, 1992

NCI Bypass Budget Seeks $3.64 Billion

January 20, 1995

NCI, Dept. of Veteran’s Affairs Sign Agreement On Clinical Trials Access

November 1, 1996

NCI Programs: BSA Approves Formation Of Two Grant Programs:

July 2, 1999

National Lung Cancer Partnership Announces Annual Grant Competition

August 9, 2013

Reports Propose Stricter Rules To Protect Research Participants

October 11, 2002